Chapter 15 Factors Underlying the Selective Vulnerability of Motor Neurons to Neurodegeneration

Blue Books of Practical Neurology

Volumn 28, Issue C, 2003, Pages

  Durham, Heather D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33544457447     PISSN: 18773419     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-3419(09)70116-3     Document Type: Article

References (174)

1. Regan R.F., and Choi D.W. Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 43 (1991) 585-591
2. Stewart G.R., Olney J.W., Pathikonda M., et al. Excitotoxicity in the embryonic chick spinal cord. Ann Neurol 30 (1991) 758-766
3. 2+ influx underlies potent induction of injury. J Neurosci 16 (1996) 5457-5465
4. Weiss J.H., and Choi D.W. Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis. Adv Neurol 56 (1991) 311-318
5. Choi D.W. Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 747 (1994) 162-171
6. Kwak S., and Nakamura R. Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists. J Neurol Sci 129 suppl (1995) 99-103
7. Rothstein J.D., and Kuncl R.W. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65 (1995) 643-651
8. Carriedo S.G., Yin H.Z., and Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16 (1996) 4069-4079
9. Regan R.F. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci Lett 213 (1996) 9-12
10. Vandenberghe W., Ihle E.C., Patneau D.K., et al. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. J Neurosci 20 (2000) 7158-7166
11. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17 (1994) 31-108
12. Seeburg P.H. The role of RNA editing in controlling glutamate receptor channel properties. J Neurochem 66 (1996) 1-5
13. Tölle T.R., Berthele A., Zieglgänsberger W., et al. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 13 (1993) 5009-5028
14. Jakowec M.W., Fox A.J., Martin L.J., et al. Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. Neuroscience 67 (1995) 893-907
15. Jakowec M.W., Yen L., and Kalb R.G. In situ hybridization analysis of AMPA receptor subunit gene expression in the developing rat spinal cord. Neuroscience 67 (1995) 909-920
16. Tomiyama M., Rodriquez-Puertas R., Cortés R., et al. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience 75 (1996) 901-915
17. Temkin R., Lowe D., Jensen P., et al. Expression of glutamate receptor subunits in alpha-motoneurons. Mol Brain Res 52 (1997) 38-45
18. Williams T.L., Day N.C., Ince P.G., et al. Calcium-permeable a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 42 (1997) 200-207
19. Morrison B.M., Janssen W.M., Gordon J.W., et al. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J Comp Neurol 395 (1998) 523-534
20. 2+ rises and consequent oxygen radical production. J Neurosci 18 (1998) 7727-7738
21. Roy J., Minotti S., Dong L., et al. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci 18 (1998) 9673-9684
22. Bar-Peled O., O'Brien R.J., Morrison J.H., et al. Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport 10 (1999) 855-859
23. 2+ overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20 (2000) 240-250
24. Greig A., Donevan S.D., Mujtaba T.J., et al. Characterization of the AMPA-activated receptors present on motoneurons. J Neurochem 74 (2000) 179-191
25. Van Damme P., Van Den B.L., Van Houtte E., et al. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J Neurophysiol 88 (2002) 1279-1287
26. Doroudchi M.M., Bianchi A.A., Sowden J.E., et al. Gene transfer of the GluR2 glutamate receptor subunit protects motor neurons in a model of familial ALS. Soc Neurosci Abstr 29 (2001) 106 11.
27. Takuma H., Kwak S., Yoshizawa T., et al. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol 46 (1999) 806-815
28. Stegenga S.L., and Kalb R.G. Developmental regulation of N-methyl-d-aspartate- and kainate-type glutamate receptor expression in the rat spinal cord. Neuroscience 105 (2001) 499-507
29. Ziv I., Achiron A., Djaldetti R., et al. Can nimodipine affect progression of motor neuron disease? A double-blind pilot study. Clin Neuropharmacol 17 (1994) 423-428
30. Miller R.G., Shepherd R., Dao H., et al. Controlled trial of nimodipine in amyotrophic lateral sclerosis. Neuromusc Disord 6 (1996) 101-104
31. Miller R.G., Smith S.A., Murphy J.R., et al. A clinical trial of verapamil in amyotrophic lateral sclerosis. Muscle Nerve 19 (1996) 511-515
32. Engelhardt J.I., Siklos L., and Appel S.H. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol 56 (1997) 21-39
33. Mohamed H.A., Mosier D.R., Zou L.L., et al. Immunoglobulin Fcgamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J Neurosci Res 69 (2002) 110-116
34. Rothstein J.D., Tsai G., Kuncl R.W., et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28 (1990) 18-25
35. Plaitakis A. Altered glutamatergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine. Adv Neurol 56 (1991) 319-326
36. Shaw P.J., Forrest V., Ince P.G., et al. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4 (1995) 209-216
37. Rothstein J.D., Martin L.J., and Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326 (1992) 1464-1468
38. Rothstein J.D., Van Kammen M., Levey A.I., et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38 (1995) 73-84
39. Bruijn L.I., Becher M.W., Lee M.K., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
40. Howland D.S., Liu J., She Y.J., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Nat Acad Sci USA 99 (2002) 1604-1609
41. Corse A.M., Bilak M.M., Bilak S.R., et al. Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol Dis 6 (1999) 335-346
42. Bensimon G., Lacomblez L., Meininger V., et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330 (1994) 585-591
43. Kruman I.I., Pedersen W.A., Springer J.E., et al. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 160 (1999) 28-39
44. Ince P., Stout N., Shaw P., et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 19 (1993) 291-299
45. Alexianu M.E., B-K H., Mohamed A.H., et al. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36 (1994) 846-858
46. Elliott J.L., and Snider W.D. Parvalbumin is a marker of ALS-resistant motor neurons. Neuroreport 6 (1995) 449-452
47. Junttila T., Koistinaho J., Reichardt L., et al. Localization of neurocalcin-like immunoreactivity in rat cranial motoneurons and spinal cord interneurons. Neurosci Lett 183 (1995) 100-103
48. Reiner A., Medina L., Figueredo-Cardenas G., et al. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp Neurol 131 (1995) 239-250
49. Palecek J., Lips M.B., and Keller B.U. Calcium dynamics and buffering in motoneurons of the mouse spinal cord. J Physiol 520 pt 2 (1999) 485-502
50. Vanselow B.K., and Keller B.U. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneuron disease. J Physiol 525 pt 2 (2000) 433-445
51. 28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci USA 93 (1996) 6796-6801
52. Ghadge G.D., Lee J.P., Bindokas V.P., et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis-molecular mechanisms of neuronal death and protection. J Neurosci 17 (1997) 8756-8766
53. Beers D.R., Ho B.K., Siklos L., et al. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem 79 (2001) 499-509
54. Van Den B.L., Schwaller B., Vleminckx V., et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol 174 (2002) 150-161
55. Klapstein G.J., Vietla S., Lieberman D.N., et al. Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: evidence from calbindin-D28k knockout mice. Neuroscience 85 (1998) 361-373
56. Philbert M.A., Beiswanger C.M., Waters D.K., et al. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthalaldehyde-induced histofluorescence. Toxicol Appl Pharmacol 107 (1991) 215-227
57. Beiswanger C.M., Diegmann M.H., Novak R.F., et al. Developmental changes in the cellular distribution of glutathione and glutathione S-transferases in the murine nervous system. Neurotoxicology 16 (1995) 425-440
58. Ratan R.R., Murphy T.H., and Baraban J.M. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 14 (1994) 4385-4392
59. Kruman I., Bruce-Keller A.J., Bredesen D., et al. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17 (1997) 5089-5100
60. Shinpo K., Kikuchi S., Sasaki H., et al. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Res 861 (2000) 151-159
61. 35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett 163 (1993) 89-92
62. Fitzmaurice P.S., Shaw I.C., and Mitchell J.D. Alteration of superoxide dismutase activity in the anterior horn in motoneuron disease patients. J Neurol Sci 129 suppl (1995) 96-98
63. Cudkowicz M.E., Pastusza K.A., Sapp P.C., et al. Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity. Neurology 59 (2002) 729-734
64. Malaspina A., Kaushik N., and De Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77 (2001) 132-145
65. Olsen M.K., Roberds S.L., Ellerbrock B.R., et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 50 (2001) 730-740
66. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 100 (1994) 47-51
67. Dugan L.L., and Choi D.W. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol 35 suppl (1994) S17-S21
68. Menzies F.M., Ince P.G., and Shaw P.J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 40 (2002) 543-551
69. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18 (1998) 3241-3250
70. Sturtz L.A., Diekert K., Jensen L.T., et al. A fraction of yeast Cu, Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria-a physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem 276 (2001) 38084-38089
71. Okado-Matsumoto A., and Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver; Cu, Zn-SOD in mitochondria. J Biol Chem 276 (2001) 38388-38393
72. Dugan L.L., Turetsky D.M., Du D., et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA 94 (1997) 9434-9438
73. Gurney M.E., Cutting F.B., Zhai P., et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39 (1996) 147-157
74. Klivenyi P., Ferrante R.J., Matthews R.T., et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5 (1999) 347-350
75. Reinholz M.M., Merkle C.M., and Poduslo J.F. Therapeutic benefits of putrescine-modified catalase in transgenic mouse model of familial amyotrophic lateral sclerosis. Exp Neurol 159 (1999) 204-216
76. Flanagan S.W., Anderson R.D., Ross M.A., et al. Overexpression of manganese superoxide dismutase attenuates neuronal death in human cells expressing mutant (G37R) Cu/Zn-superoxide dismutase. J Neurochem 81 (2002) 170-177
77. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS [review]. Nat Rev Neurosci 2 (2001) 806-819
78. Oosthuyse B., Moons L., Storkebaum E., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28 (2001) 131-138
79. Silverstein F.S., and Nelson C. The microsomal calcium-ATPase inhibitor thapsigargin is a neurotoxin in perinatal rodent brain. Neurosci Lett 145 (1992) 157-160
80. Hodgson A.V., White T.B., White J.W., et al. Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction. Mol Cell Biochem 120 (1993) 171-179
81. Hansson T., Tindberg N., Ingelman-Sundberg M., et al. Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system. Neuroscience 34 (1990) 451-463
82. Volk B., Hettmannsperger U., Papp T., et al. Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system. Neuroscience 42 (1991) 215-235
83. Marcuccilli C.J., and Miller R.J. CNS stress response: too hot to handle?. Trends Neurosci 17 (1994) 135-138
84. Morimoto R.I., Kline M.P., Bimston D.N., et al. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 32 (1997) 17-29
85. Baumeister W., Walz J., Zuhl F., et al. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92 (1998) 367-380
86. Sherman M.Y., and Goldberg A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases [review]. Neuron 29 (2001) 15-32
87. Manzerra P., and Brown I.R. Expression of heat shock genes (hsp70) in the rabbit spinal cord: localization of constitutive and hyperthermia-inducible mRNA species. J Neurosci Res 31 (1992) 606-615
88. Manzerra P., and Brown I.R. The neuronal stress response: nuclear translocation of heat shock proteins as an indicator of hyperthermic stress. Exp Cell Res 229 (1996) 35-47
89. Sakurai M., Aoki M., Abe K., et al. Dissociation of HSP72 and HSC73 heat shock mRNA inductions after spinal cord ischemia in rabbit. Neurosci Lett 217 (1996) 113-116
90. Batulan Z.B., Minotti S., Figlewicz D.A., et al. High threshold for activation of the stress response in motor neurons: a source of vulnerability in ALS?. Soc Neurosci Abstr 26 (2000) 85 15.
91. Johnston J.A., Dalton M.J., Gurney M.E., et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97 (2000) 12571-12576
92. Shinder G.A., Lacourse M.C., Minotti S., et al. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem 276 (2001) 12791-12796
93. Bailey C.K., Andriola I.F., Kampinga H.H., et al. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet 11 (2002) 515-523
94. Goedert M., Spillantini M.G., and Davies S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8 (1998) 619-632
95. Paulson H.L., and Fischbeck K.H. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 19 (1998) 79-107
96. Kabakov A.E., and Gabai V.L. Protein aggregation as primary and characteristic cell reaction to various stresses. Experientia 49 (1993) 706-713
97. Mifflin L.C., and Cohen R.E. Characterization of denatured protein inducers of the heat shock (stress) response in Xenopus laevis oocytes. J Biol Chem 269 (1994) 15710-15717
98. Johnston J.A., Ward C.L., and Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143 (1998) 1883-1898
99. Bruening W., Roy J., Giasson B., et al. Upregulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J Neurochem 72 (1999) 693-699
100. Ward C.M., Liu J., Young D.J., et al. Increasing the protein folding chaperone HSP70 does not affect time course of SOD1-mutant-mediated amyotrophic lateral sclerosis. Soc Neurosci Abstr 27 (2001) 107 12.
101. Mathew A., Mathur S.K., and Morimoto R.I. Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. Mol Cell Biol 18 (1998) 5091-5098
102. Mathew A., Mathur S.K., Jolly C., et al. Stress-specific activation and repression of heat shock factors 1 and 2. Mol Cell Biol 21 (2001) 7163-7171
103. Pasquini L.A., Besio M.M., Adamo A.M., et al. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J Neurosci Res 59 (2000) 601-611
104. Qiu J.H., Asai A., Chi S., et al. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20 (2000) 259-265
105. Suzuki Y., Nakabayashi Y., and Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 98 (2001) 8662-8667
106. Ratovitski T., Corson L.B., Strain J., et al. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet 8 (1999) 1451-1460
107. Hoffman E.K., Wilcox H.M., Scott R.W., et al. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J Neurol Sci 139 (1996) 15-20
108. Ding Q.X., and Keller J.N. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem 77 (2001) 1010-1017
109. Oeda T., Shimohama S., Kitagawa N., et al. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet 10 (2001) 2013-2023
110. Manetto V., Sternberger N.H., Perry G., et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 47 (1988) 642-653
111. Murayama S., Bouldin T.W., and Suzuki K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 83 (1992) 518-524
112. Sobue G., Hashizume Y., Yasuda T., et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol 79 (1990) 402-408
113. Kato S., and Hirano A. Ubiquitin and phosphorylated neurofilament epitopes in ballooned neurons of the extraocular muscle nuclei in a case of Werdnig-Hoffmann disease. Acta Neuropathol 80 (1990) 334-337
114. Murayama S., Bouldin T.W., and Suzuki K. Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease. Acta Neuropathol 81 (1991) 408-417
115. Bizzi A., and Gambetti P. Phosphorylation of neurofilament is altered in aluminum intoxication. Acta Neuropathol 71 (1986) 154-158
116. Troncoso J.C., Sternberger N.H., Sternberger L.A., et al. Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain Res 364 (1986) 295-300
117. Hugon J., and Vallat J.M. Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid. Neurosci Lett 119 (1990) 45-48
118. Watson D.F., Griffin J.W., Fittro K.P., et al. Phosphorylation-dependent immunoreactivity of neurofilaments increases during axonal maturation and beta, beta'-iminodipropionitrile intoxication. J Neurochem 53 (1989) 1818-1829
119. Watson D.F., Fittro K.P., Hoffman P.N., et al. Phosphorylation-related immunoreactivity and the rate of transport of neurofilament in chronic 2,5-hexamidine intoxication. Brain Res 539 (1991) 103-109
120. Goldstein M.E., Cooper H.S., Bruce J., et al. Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerve. J Neurosci 7 (1987) 1586-1594
121. Mansour H., Bignami A., Labkovsky B., et al. Neurofilament phosphorylation in neuronal perikarya following axotomy: a study of rat spinal cord with central and dorsal root transection. J Comp Neurol 283 (1989) 481
122. Martin J.E., Mather K.S., Swash M., et al. Spinal cord trauma in man-studies of phosphorylated neurofilament and ubiquitin expression. Brain 113 (1990) 1553-1562
123. 2+ dependent. Neuroreport 6 (1995) 945-948
124. Wuerker R., and Palay S.L. Neurofilaments and microtubules in anterior horn cells of the rat. Tissue Cell 1 (1969) 387-402
125. Kaiserman-Abramoff I.R., and Peters A. Some aspects of the morphology of Betz cells in the cerebral cortex of the cat. Brain Res 43 (1972) 527-546
126. Wuerker R.B., and Kirkpatrick J.B. Neuronal microtubules, neurofilaments, and microfilaments. Int Rev Cytol 33 (1972) 45-75
127. Nakano I., and Hirano A. Atrophic cell processes of large motor neurons in the anterior horn in amyotrophic lateral sclerosis: observation with silver impregnation method. J Neuropathol Exp Neurol 46 (1987) 40-49
128. Carpenter S., Karpati G., and Durham H. Dendritic attrition precedes motor neuron death in amyotrophic lateral sclerosis (ALS). Neurology 34 (1988) 252
129. Durham H.D., Karpati G., and Carpenter S. The Pathogenesis and Significance of Dendritic Atrophy in Amyotrophic Lateral Sclerosis. In: Rose F.C., and Norris F.H. (Eds). ALS. New Advances in Toxicology and Epidemiology (1990), Smith-Gordon, London
130. Zhang Z., Casey D.M., Julien J.P., et al. Normal dendritic arborization in spinal motoneurons requires neurofilament subunit L. J Comp Neurol 450 (2002) 144-152
131. Hoffman P.N., Cleveland D.W., Griffin J.W., et al. Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci USA 84 (1987) 3472-3476
132. Spencer P.S., Allen C.N., Kisby G.E., et al. On the etiology and pathogenesis of chemically induced neurodegenerative disorders. Neurobiol Aging 15 (1994) 265-267
133. Julien J.P., and Mushynski W.E. Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol 61 (1998) 1-23
134. J-P J., and Mushynski W.E. The distribution of phosphorylation sites among identified fragments of mammalian neurofilaments. J Biol Chem 258 (1983) 4019-4025
135. Giasson B.I., and Mushynski W.E. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J Biol Chem 271 (1996) 30404-30409
136. Grant P., Sharma P., and Pant H.C. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. Eur J Biochem 268 (2001) 1534-1546
137. Nguyen M.D., Lariviere R.C., and Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 (2001) 135-147
138. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci 14 (1991) 501-506
139. Sanchez I., Hassinger L., Sihag R.K., et al. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation. J Cell Biol 151 (2000) 1013-1024
140. Veronesi B., Peterson E.R., Bornstein M.B., et al. Ultrastructural studies of the dying-back process, VI: examination of nerve fibers undergoing giant axonal degeneration in organotypic culture. J Neuropathol Exp Neurol 42 (1983) 153-165
141. Durham H.D. An antibody against hyperphosphorylated neurofilament proteins collapses the neurofilament network in motor neurons but not in dorsal root ganglion cells. J Neuropathol Exp Neurol 51 (1992) 287-297
142. Côté F., J-F C., and J-P J. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 (1993) 35-46
143. Xu Z., Cork L.C., Griffin J.W., et al. Involvement of neurofilaments in motor neuron disease. J Cell Sci 106 suppl 17 (1993) 101-108
144. Wong P.C., Marszalek J., Crawford T.O., et al. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol 130 (1995) 1413-1422
145. Lee M.K., Marszalek J.R., and Cleveland D.W. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease. Neuron 13 (1994) 975-988
146. Figlewicz D.A., Krizus A., Martinoli M.G., et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3 (1994) 1757-1761
147. Tomkins J., Usher P., Slade J.Y., et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9 (1998) 3967-3970
148. Al-Chalabi A., Andersen P.M., Nilsson P., et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8 (1999) 157-164
149. Meier J., Couillard-Després S., Jacomy H., et al. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol 58 (1999) 1099-1110
150. Wong N., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 59 (2000) 972-982
151. Menzies F.M., Grierson A.J., Cookson M.R., et al. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J Neurochem 82 (2002) 1118-1128
152. Williamson T.L., Bruijn L.I., Zhu Q., et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 95 (1998) 9631-9636
153. Couillard-Després S., Zhu Q., Wong P.C., et al. Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci USA (1998) 95
154. Lefebvre S., and Mushynski W.E. Calcium binding to untreated and dephosphorylated porcine neurofilaments. Biochem Biophys Res Commun 145 (1987) 1006-1011
155. Corbo M., and Hays A.P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J Neuropathol Exp Neurol 51 (1992) 531-537
156. Migheli A., Pezzulo T., Attanasio A., et al. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab Invest 68 (1993) 185-191
157. Tu P.H., Raju P., Robinson K.A., et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93 (1996) 3155-3160
158. Beaulieu J.M., Nguyen M.D., and Julien J.P. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol 147 (1999) 531-544
159. Robertson J., Beaulieu J.M., Doroudchi M.M., et al. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J Cell Biol 155 (2001) 217-226
160. Pramatarova A., Laganiere J., Roussel J., et al. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21 (2001) 3369-3374
161. Lino M.M., Schneider C., and Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22 (2002) 4825-4832
162. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 459-470
163. Verbeke P., Fonager J., Clark B.F., et al. Heat shock response and ageing: mechanisms and applications. Cell Biol Int 25 (2001) 845-857
164. Terman A. Garbage catastrophe theory of aging: imperfect removal of oxidative damage?. Redox Rep 6 (2001) 15-26
165. Keller J.N., Huang F.F., and Markesbery W.R. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98 (2000) 149-156
166. Brunk U., and Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33 (2002) 611
167. Cuervo A.M., and Dice J.F. Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med 76 (1998) 6-12
168. Cuervo A.M., and Dice J.F. Age-related decline in chaperone-mediated autophagy. J Biol Chem 275 (2000) 31505-31513
169. Andrus P.K., Fleck T.J., Gurney M.E., et al. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71 (1998) 2041-2048
170. Bajaj N.P., Al Sarraj S.T., Anderson V., et al. Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci Lett 245 (1998) 45-48
171. Squier T.C., and Bigelow D.J. Protein oxidation and age-dependent alterations in calcium homeostasis. Front Biosci 5 (2000) D504-D526
172. Wei Y.H., and Lee H.C. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 227 (2002) 671-682
173. Cotrina M.L., and Nedergaard M. Astrocytes in the aging brain. J Neurosci Res 67 (2002) 1-10
174. Deitch J.S., Alexander G.M., Del Valle L., et al. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1. J Neurol Sci 193 (2002) 117-126